To explore whether the knockdown of Tug1 could promote antitumor immunity in HCC, we established an orthotopic mouse model of HCC with sh‐NC and sh‐Tug1 Hepa1‐6 cells and performed flow cytometry. Here, TUG1 is linked to hepatocellular carcinoma.